Purezen's SugarStopper Clinical Study Shows Average HbA1c Drop from 7.5% to 5.95% in 90 Days
India, Oct. 27 -- HT Syndication
Mumbai (Maharashtra) [India], October 27: Mumbai based Purezen Health Solutions Pvt. Ltd. known for its evidence-based supplements built around real health outcomes, today released results from an independent 90-day clinical study on its blood sugar metabolic boost support supplement - SugarStopper*.
Conducted by an independent clinical research organisation in Bengaluru, the study followed 30 adults aged 22 to 57 who were already on prescribed medication for elevated blood sugar. Participants took two SugarStopper capsules daily for 90 days, alongside their existing treatment, with no change to their prescribed medicines.
The findings:
· Average HbA1c fell from 7.5% to 5.95% over 90 days - a redu...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.